Figure 1.
Figure 1. Forest plot of the risk of VOE in patients with Ph+ leukemia treated with new generation TKIs versus imatinib.

Forest plot of the risk of VOE in patients with Ph+ leukemia treated with new generation TKIs versus imatinib.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal